Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation.

The use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is increasing, but studies evaluating clinical outcomes in these patients are scarce. Also, there are limited data to guide the choice of valve type in ViV-TAVI. Therefore, this CENTER-study evaluated clinical outcomes in patients with ViV-TAVI compared to patients with native valve TAVI (NV-TAVI).

Familial restrictive cardiomyopathy with atrioventricular block without skeletal myopathy.

Familial restrictive cardiomyopathy is an autosomal dominant cardiomyopathy histologically characterized by myocyte hypertrophy and interstitial fibrosis. The case of a 54-year-old man diagnosed with restrictive cardiomyopathy is reported. The patient had been implanted with a two-chambered pacemaker for a complete atrioventricular block 12 years before.